Nexgel Inc Stock Performance
| NXGL Stock | USD 2.79 0.05 1.76% |
The company secures a Beta (Market Risk) of 1.96, which conveys a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Nexgel will likely underperform. At this point, Nexgel Inc has a negative expected return of -0.72%. Please make sure to verify Nexgel's potential upside, rate of daily change, as well as the relationship between the Rate Of Daily Change and relative strength index , to decide if Nexgel Inc performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Over the last 90 days Nexgel Inc has generated negative risk-adjusted returns adding no value to investors with long positions. Despite conflicting performance in the last few months, the Stock's technical and fundamental indicators remain quite persistent which may send shares a bit higher in April 2025. The latest mess may also be a sign of long-standing up-swing for the company institutional investors. ...more
Actual Historical Performance (%)
One Day Return (1.90) | Five Day Return (3.26) | Year To Date Return (27.26) | Ten Year Return (20.85) | All Time Return (20.85) |
Last Split Factor 3:2 | Last Split Date 1990-08-02 |
1 | Disposition of 3000 shares by Henry Scott Robert of Nexgel at 4.6449 subject to Rule 16b-3 | 12/20/2024 |
2 | Insider Trading | 12/31/2024 |
3 | Acquisition by Adam Levy of 150000 shares of Nexgel at 3.829 subject to Rule 16b-3 | 01/02/2025 |
4 | Disposition of 3000 shares by Henry Scott Robert of Nexgel at 3.3655 subject to Rule 16b-3 | 01/07/2025 |
5 | Acquisition by Toledano Miranda Jayne of 1819 shares of Nexgel at 5.49 subject to Rule 16b-3 | 01/23/2025 |
6 | Acquisition by Henry Scott Robert of 1000 shares of Nexgel at 1.9 subject to Rule 16b-3 | 01/24/2025 |
7 | Disposition of 4000 shares by Adam Levy of Nexgel at 3.6394 subject to Rule 16b-3 | 02/03/2025 |
8 | Nexgel CEO Adam Levy sells 14,557 in common stock - MSN | 02/07/2025 |
9 | Disposition of 3000 shares by Henry Scott Robert of Nexgel at 3.2661 subject to Rule 16b-3 | 02/10/2025 |
10 | Acquisition by Henry Scott Robert of 2500 shares of Nexgel subject to Rule 16b-3 | 02/12/2025 |
11 | NEXGEL to Participate in Webull Consumer Virtual Webinar on February 18, 2025 | 02/13/2025 |
12 | Disposition of 4000 shares by Adam Levy of Nexgel at 3.1597 subject to Rule 16b-3 | 03/03/2025 |
13 | Acquisition by Stein Nachum of 100 shares of Nexgel at 1.2 subject to Rule 16b-3 | 03/05/2025 |
14 | Disposition of 3000 shares by Henry Scott Robert of Nexgel at 2.8737 subject to Rule 16b-3 | 03/10/2025 |
15 | NEXGEL CEO to Present at iAccess Alpha Virtual Investment Conference - MSN | 03/14/2025 |
| Begin Period Cash Flow | 1.1 M |
Nexgel |
Nexgel Relative Risk vs. Return Landscape
If you would invest 462.00 in Nexgel Inc on December 19, 2024 and sell it today you would lose (178.00) from holding Nexgel Inc or give up 38.53% of portfolio value over 90 days. Nexgel Inc is currently does not generate positive expected returns and assumes 4.1935% risk (volatility on return distribution) over the 90 days horizon. In different words, 37% of stocks are less volatile than Nexgel, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Nexgel Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Nexgel's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Nexgel Inc, and traders can use it to determine the average amount a Nexgel's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.1717
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | NXGL |
Estimated Market Risk
| 4.19 actual daily | 37 63% of assets are more volatile |
Expected Return
| -0.72 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.17 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Nexgel is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Nexgel by adding Nexgel to a well-diversified portfolio.
Nexgel Fundamentals Growth
Nexgel Stock prices reflect investors' perceptions of the future prospects and financial health of Nexgel, and Nexgel fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Nexgel Stock performance.
| Return On Equity | -0.68 | ||||
| Return On Asset | -0.24 | ||||
| Profit Margin | (0.52) % | ||||
| Operating Margin | (0.27) % | ||||
| Current Valuation | 21.83 M | ||||
| Shares Outstanding | 6.79 M | ||||
| Price To Book | 4.19 X | ||||
| Price To Sales | 2.87 X | ||||
| Revenue | 4.09 M | ||||
| Gross Profit | 2.13 M | ||||
| EBITDA | (2.73 M) | ||||
| Net Income | (3.16 M) | ||||
| Cash And Equivalents | 9.79 M | ||||
| Cash Per Share | 1.76 X | ||||
| Total Debt | 2.8 M | ||||
| Debt To Equity | 0.36 % | ||||
| Current Ratio | 4.33 X | ||||
| Book Value Per Share | 0.69 X | ||||
| Cash Flow From Operations | (3.24 M) | ||||
| Earnings Per Share | (0.59) X | ||||
| Market Capitalization | 19.29 M | ||||
| Total Asset | 9.96 M | ||||
| Retained Earnings | (14.71 M) | ||||
| Working Capital | 2.5 M | ||||
About Nexgel Performance
By examining Nexgel's fundamental ratios, stakeholders can obtain critical insights into Nexgel's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Nexgel is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 124.87 | 131.11 | |
| Return On Tangible Assets | (0.33) | (0.35) | |
| Return On Capital Employed | (0.42) | (0.44) | |
| Return On Assets | (0.29) | (0.30) | |
| Return On Equity | (0.60) | (0.64) |
Things to note about Nexgel Inc performance evaluation
Checking the ongoing alerts about Nexgel for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Nexgel Inc help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Nexgel Inc generated a negative expected return over the last 90 days | |
| Nexgel Inc has high historical volatility and very poor performance | |
| Nexgel Inc has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the previous year's revenue of 4.09 M. Net Loss for the year was (3.16 M) with profit before overhead, payroll, taxes, and interest of 2.13 M. | |
| Nexgel Inc currently holds about 9.79 M in cash with (3.24 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.76. | |
| Roughly 21.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from news.google.com: NEXGEL CEO to Present at iAccess Alpha Virtual Investment Conference - MSN |
- Analyzing Nexgel's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Nexgel's stock is overvalued or undervalued compared to its peers.
- Examining Nexgel's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Nexgel's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Nexgel's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Nexgel's stock. These opinions can provide insight into Nexgel's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nexgel Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Nexgel. If investors know Nexgel will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Nexgel listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.59) | Revenue Per Share | Quarterly Revenue Growth 1.408 | Return On Assets | Return On Equity |
The market value of Nexgel Inc is measured differently than its book value, which is the value of Nexgel that is recorded on the company's balance sheet. Investors also form their own opinion of Nexgel's value that differs from its market value or its book value, called intrinsic value, which is Nexgel's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Nexgel's market value can be influenced by many factors that don't directly affect Nexgel's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Nexgel's value and its price as these two are different measures arrived at by different means. Investors typically determine if Nexgel is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Nexgel's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.